Read about Recursive's Flint AI coding model, its laptop-friendly design, coding benchmarks, open-source license, and Eureka ...

Recursion Pharmaceuticals Inc. RXRX shares are trending on Friday. Shares of the Utah-based clinical-stage biotechnology company edged 0.24% higher to $4.17 after the bell on Thursday, following a ...

When studying programming, you notice something strange.Processes that are extremely complex for humans to think through can ...

Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) snapped a three-day winning streak on Thursday, surging as much as 17.9 percent intraday, after Sanofi finally pulled the trigger on the development of ...

What happens when an AI becomes capable of observing itself, modifying its internal structure, and retraining itself? Using ...

A harmonic increment provides a new way to improve smooth approximations of the minimum function. In a recent paper, ...

LMSYS Org, the nonprofit behind the open-source AI engine SGLang, today announced the speakers and program for the SGLang ...

Europe's defense tech sector is attracting record investment, but funding gaps, reliance on US capital, and fragmented ...

Anthropic faces intense competitive pressure and huge fixed costs. Can Claude build itself fast enough to succeed?

A prominent researcher claims to have a revolutionary approach to “interpretability,” or the science of why A.I. models do ...

Recursion Pharmaceuticals announced a $10 million milestone payment from Sanofi for a new drug candidate targeting inflammatory diseases.